Quote
—
—
No scored catalysts in the window yet.
Market cap
—
P/E
—
EPS
—
Beta
—
52W range
—
Day range
—
Open
—
Prev close
—
Volume
—
Avg volume
—
Dividend
—
IPO
—
https://www.proactiveinvestors.co.uk/companies/news/1095824 · 7/22/2026+0.60
https://www.proactiveinvestors.co.uk/companies/news/1094477 · 6/25/2026+0.60
https://www.proactiveinvestors.co.uk/companies/news/1094390 · 6/24/2026+0.60
https://www.proactiveinvestors.co.uk/companies/news/1092936 · 5/27/2026+0.60
https://www.proactiveinvestors.co.uk/companies/news/1091691 · 5/5/2026+0.60
https://www.proactiveinvestors.co.uk/companies/news/1091153 · 4/24/2026+0.70
https://www.proactiveinvestors.co.uk/companies/news/1090886 · 4/21/2026+0.70
https://www.proactiveinvestors.co.uk/companies/news/1090236 · 4/9/2026+0.90
https://www.proactiveinvestors.co.uk/companies/news/1089255 · 3/21/2026+0.70
https://www.proactiveinvestors.co.uk/companies/news/1089023 · 3/17/2026+0.60
https://www.defenseworld.net/2026/03/15/immupharma-lonimm-trading-up-0-9-should-you-buy.html · 3/15/2026+0.10
https://www.globenewswire.com/news-release/2025/12/16/3206183/0/en/Immutep-Announces-Strong-Operational-Progress-in-Global-TACTI-004-KEYNOTE-F91-Phase-III-and-Enrolment-Continues-at-Robust-Pace.html · 12/16/2025+0.80
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works